Disease-modifying approach to cardiovascular–kidney–metabolic syndrome: The role of combining GLP-1RAs and SGLT-2is

Sanja Borozan, Cornelius J Fernandez, ABM Kamrul-Hasan, Joseph M Pappachan

Open source

DOI
10.17925/ee.2026.22.2.5
Published
2026-10
Container
touchREVIEWS in Endocrinology
Publisher
Touch Medical Media, Ltd.
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.17925/ee.2026.22.2.5,
  title = {Disease-modifying approach to cardiovascular–kidney–metabolic syndrome: The role of combining GLP-1RAs and SGLT-2is},
  author = {Sanja Borozan and Cornelius J Fernandez and ABM Kamrul-Hasan and Joseph M Pappachan},
  year = {2026},
  journal = {touchREVIEWS in Endocrinology},
  doi = {10.17925/ee.2026.22.2.5},
  url = {https://doi.org/10.17925/ee.2026.22.2.5}
}

RIS

TY  - JOUR
TI  - Disease-modifying approach to cardiovascular–kidney–metabolic syndrome: The role of combining GLP-1RAs and SGLT-2is
AU  - Sanja Borozan
AU  - Cornelius J Fernandez
AU  - ABM Kamrul-Hasan
AU  - Joseph M Pappachan
PY  - 2026
JO  - touchREVIEWS in Endocrinology
DO  - 10.17925/ee.2026.22.2.5
UR  - https://doi.org/10.17925/ee.2026.22.2.5
ER  - 

APA

Borozan, S., Fernandez, C. J., Kamrul-Hasan, A., & Pappachan, J. M. (2026). Disease-modifying approach to cardiovascular–kidney–metabolic syndrome: The role of combining GLP-1RAs and SGLT-2is. touchREVIEWS in Endocrinology. https://doi.org/10.17925/ee.2026.22.2.5

Source records